Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)
Alkermes plc (Nasdaq: ALKS) today announced topline results from a phase 3, open-label extension study assessing the long-term safety, tolerability and durability of treatment effect of LYBALVI® (olanzapine and samidorphan) in patients with schizophrenia, schizophreniform disorder or bipolar I disorder for up to…
Ketamine Clinics Los Angeles (KCLA) Announces Free, Informative Webinar to Address Misconceptions Surrounding the Death of Actor Matthew Perry
Due to the media storm surrounding the recently announced cause of death for late actor Matthew Perry and his reported use of ketamine at the time of his death, leading mental health treatment center Ketamine Clinics Los Angeles (KCLA) announces a free, first-of-its-kind webinar…
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it has signed a License Data and Technical Information Agreement with Columbia University for rights to data from a randomized, active-controlled trial of 80 patients hospitalized for…
New Eating Disorder Care Center in Saylorsburg Expands Rural Treatment Options for Adolescents
Blue Ridge Eating Disorder Center, a treatment facility in a homelike setting, promises quality care for our rural community. “Eating disorders don’t discriminate to affecting just those who live in big cities or populated areas, and our staff believe that…
Peach State Health Plan, Pyx Health Announce Partnership to Combat Social Isolation, Loneliness and Depression in Georgia Youth
Today, Peach State Health Plan, a care management organization that serves the needs of Georgians through a range of health insurance solutions and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced a new partnership with Pyx Health, a health care technology company, in a…
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a company dedicated to transforming the multi-billion dollar acute respiratory care market with the INSPIRA ART medical device line, is pleased to announce the recent approval of a grant from the…
NRx Pharmaceuticals and Nephron Pharmaceuticals Announce Joint Agreement to Develop Intravenous Ketamine to Treat Suicidal Depression
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, (NRx), a clinical-stage biopharmaceutical company and Nephron Pharmaceuticals, Inc. (Nephron), a leading manufacturer of sterile injectable drugs today announced the signing of a development and manufacturing agreement to manufacture a presentation of ketamine suitable…
Essential Oil Company ĒLYSCE Launches Full Line of Aromatherapy Products Geared at Addressing Mental Health Concerns, Nurturing Happiness, and Promoting Overall Well-Being
ĒLYSCE, the newest essential oil company to hit the market, is thrilled to announce its full line of U.S.-made, high-quality essential oils and accessories, with a core mission of promoting the power of natural therapeutics. Committed to ensuring that everyone…
Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression
Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINT™ Neuromodulation System for treating major depressive disorder (MDD) as part of a larger multi-site trial to further develop a more rapid, personalized treatment…
Caminar to Host Annual Fall Celebration on November 4th to Increase Mental Health Awareness and Foster Courage, Hope and Community
Caminar, a leading Bay Area behavioral health care agency, is continuing its mission to reduce the stigma around mental health and encourage ongoing mental health advocacy through its annual celebration on Saturday, November 4, 2023. The event is open to…
